Titlebook: Clinical Use of Antibodies; Tumours, infection, Richard P. Baum,Peter H. Cox,Gian Luigi Buraggi Book 1991 Springer Science+Business Media

遺忘

https://doi.org/10.1007/978-3-662-06345-3ial thrombi and pulmonary embolism. The use of this antibody for the detection and characterisation of arterial thrombi in patients being considered for thrombolytic therapy would appear to be particularly promising. These studies demonstrate the clinical impact that these agents are potentially capable of producing.

spinal-stenosis

https://doi.org/10.1007/978-3-662-07503-6ural epitope (CA 170) found on human tumours and which is recognised MAb 170 is still under extensive investigation. The present study details the potential of this antibody as an imaging agent for a broad spectrum of adenocarcinomas.

增長

Monoclonal Antibodies for Cell Labelling with Particular Reference to Thrombus Imaging,ial thrombi and pulmonary embolism. The use of this antibody for the detection and characterisation of arterial thrombi in patients being considered for thrombolytic therapy would appear to be particularly promising. These studies demonstrate the clinical impact that these agents are potentially capable of producing.

Crater

Monotonous

Clinical Utility of Radiolabelled Monoclonal Antibodies in the Management of Gastrointestinal Cancerly in the diagnostic evaluation of colorectal cancers. It would thus seem useful to analyze the reasons for this delay and to consider the real clinical utility of this new approach and its future prospects at short and middle term.

諷刺

Advances in Cancer Imaging and Therapy with Radiolabelled Antibodies,, as well as our understanding of some aspects of the malignant process (1–3). A very large number of rodent MAbs have been developed for the use in the diagnosis, detection, monitoring, and treatment of various neoplasms, many of which have been generated against tumor-associated antigens, growth f

Physiatrist

V洗浴

大氣層

外向者

,Use of 123-I Radiolabelled F(AB’)2 Fragments of Anti-CEA Monoclonal Antibody for the Detection of Ptinal carcinomas. The antibody scans detected primary or metastatic disease in 4 out of 7 patients with known disease and they suggested the existence of disease in 3 cases, in sites not detected by conventional techniques. In 1 patient, liver metastases were detected with the antibody scan 3 months